SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient

Rudolphi-Solero, T.Rashki, M.Fernandez-Fernandez, J.Rivas-Navas, D.Ramos-Font, C.Rodriguez-Fernandez, A.2025-01-072025-01-072023-01-172253-654Xhttps://hdl.handle.net/10668/26272enSARS-COV-2 virus triggers immune antitumor response in a lymphoma patienteditorial34074622open access10.1016/j.remn.2021.04.005https://doi.org/10.1016/j.remn.2021.04.0051031147000001